Dr Hidde Bleijendaal (Amsterdam University Medical Center, the Netherlands) presented a study aimed to evaluate whether ECG-based machine learning models can predict all-cause, in-hospital mortality in COVID-19 patients and to identify ECG features associated with mortality [1]. Included were 882 patients admitted with COVID-19 in 7 different Dutch hospitals. Raw-format 12-lead ECGs recorded after admission (<72 hours) were collected, manually assessed, and annotated using pre-defined ECG features. Using data from 5 of the 7 centres (n=634), 2 mortality prediction models were developed. The first prediction model was a multivariate logistic regression (LASSO) model adding manually extracted ECG features and was used to identify ECG features associated with mortality. The second was a deep learning model (DNN) developed using raw-format ECGs, age, and sex. To implement transfer learning, a pre-trained model (large dataset, different task) fine-tuned for current prediction task was used. A baseline model was created using only age and sex to evaluate the added value of ECG. Data from 2 other centres (n=248) were used for external validation.
Performance of both prediction models was similar, with a mean area under the ROC of 0.76 (95% CI 0.68–0.82) for the LASSO model (sensitivity 0.86, specificity 0.54) and 0.77 (95% CI 0.70-0.83) for the DNN in the external validation cohort (sensitivity 0.86, specificity 0.57). Respective results for the baseline model were slightly lower or similar: AUC was 0.76 (95% CI 0.68–0.82), sensitivity was 0.87, and specificity was 0.49. After adjustment for age and sex, increased ventricular rate, right bundle branch block, ST-depression, and low QRS voltages remained as significant predictors for mortality in COVID-19 patients.
Dr Bleijendaal concluded, “Predication of mortality in this dataset in COVID-19 patients is mostly based on age and sex. However, by adding ECG data we did improve the AUC slightly. The added value of the ECG seems to be present but is limited.”
- Bleijendaal H. Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning. EHRA 2021 Congress, 23-25 April.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Early rhythm-control ablation: insight from the CHARISMA registry Next Article
The precordial R-prime wave: a discriminator between cardiac sarcoidosis and ARVC »
« Early rhythm-control ablation: insight from the CHARISMA registry Next Article
The precordial R-prime wave: a discriminator between cardiac sarcoidosis and ARVC »
Table of Contents: EHRA 2021
Featured articles
Atrial Fibrillation and Direct Oral Anticoagulant
Predictors of young-onset atrial fibrillation
RACE 3 long-term results show fading benefit of targeted therapies in AF and HF
Deep dive into EAST-AFNET 4 results on early rhythm-control in atrial fibrillation
Cryo-FIRST study: improved AF and QoL outcomes with cryoballoon versus drug therapy
STROKESTOP: Benefits of systematic screening for atrial fibrillation
DOACs and bleeding: the role of antidotes
2021 EHRA practical guide: DOACs in pre-operative and bleeding patients
Atrial Ablation
Early rhythm-control ablation: insight from the CHARISMA registry
Personalised pulmonary vein isolation procedure feasible and effective
Pulmonary vein isolation: cryoballoon non-inferior to radiofrequency ablation
Diagnostic Tools
EHRA Practical Guide on cardiac imaging in electrophysiology
Novel diagnostic score accurately differentiates between athlete’s heart and ARVC
The precordial R-prime wave: a discriminator between cardiac sarcoidosis and ARVC
Limited added value of ECG-based mortality prediction in COVID-19 patients using machine learning
Devices
EHRA expert statement on pacemakers and intracardial devices: “watch out for the little old lady”
5-Year efficacy of subcutaneous implantable cardioverter defibrillator
Specific Populations
Individualised approaches key to success in resynchronisation therapy non-responders
Antiarrhythmic drug treatment in children: evidence-based recommendations
The importance of cardiac imaging in patients with congenital heart disease
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com